```html

Yellow Plaques on Elbows (Xanthomas)

What is Yellow plaques on elbows (xanthomas)?

Yellow plaques that appear on the elbows, knees, or other extensor surfaces are called xanthomas. They are collections of lipid‑rich (fat) material that have accumulated within the skin’s connective tissue, giving them a characteristic yellow‑orange hue and a slightly raised, plaque‑like texture. While a single small plaque may be harmless, multiple or large xanthomas often signal an underlying disorder of lipid metabolism or another systemic condition.

Xanthomas are not infectious and cannot be spread to other skin areas by touching. Their appearance is usually slow, developing over weeks to months, and they may become firmer or more pronounced if the underlying lipid abnormality is not addressed.

Common Causes

Below are the most frequent conditions associated with yellow elbow plaques:

• Familial hypercholesterolemia (FH) – a genetic defect in LDL‑receptor function leading to high LDL‑cholesterol.
• Primary (familial) hypertriglyceridemia – elevated VLDL/triglycerides often produce eruptive xanthomas.
• Familial combined hyperlipidemia – mixed elevation of LDL, VLDL, and triglycerides.
• Type III hyperlipoproteinemia (Dysbetalipoproteinemia) – defective ApoE results in large, flat “tubero‑eruptive” xanthomas on elbows and knees.
• Secondary hyperlipidemia due to uncontrolled diabetes mellitus – poor glycemic control raises triglycerides and LDL.
• Cholestatic liver disease (e.g., primary biliary cholangitis, biliary obstruction) – impaired bile excretion causes lipid accumulation.
• Nephrotic syndrome – heavy protein loss leads to hepatic overproduction of lipoproteins.
• Hypothyroidism – reduced LDL‑receptor activity raises serum cholesterol.
• Medication‑induced hyperlipidemia – drugs such as cyclosporine, sirolimus, or certain retinoids.
• Rare metabolic disorders – e.g., sitosterolemia, LCAT deficiency.

Associated Symptoms

Patients with xanthomas often experience other signs that reflect the underlying disease:

• Other skin lesions – tendinous xanthomas (Achilles tendon), eruptive xanthomas, or planar xanthomas on the face.
• Cardiovascular complaints – chest pain, shortness of breath, or claudication from atherosclerotic plaque buildup.
• Abdominal pain or hepatomegaly – seen in cholestatic liver disease.
• Frequent urination, excessive thirst, or weight loss – classic diabetes mellitus features.
• Swelling around the eyes (periorbital edema) or in the lower extremities – typical for nephrotic syndrome.
• Fatigue, cold intolerance, and constipation – symptoms of hypothyroidism.

When to See a Doctor

Prompt evaluation is advisable if any of the following occur:

• The plaques are rapidly enlarging or becoming painful.
• You notice new lesions on other parts of the body, especially tendons or the eyelids.
• There are accompanying symptoms such as chest pain, unexplained weight loss, or severe fatigue.
• You have a personal or family history of high cholesterol, early heart disease, or diabetes.
• Any signs of liver dysfunction (jaundice, dark urine) or kidney disease (frothy urine, swelling).

Diagnosis

Evaluation typically proceeds in three steps: visual assessment, laboratory testing, and, when needed, imaging or biopsy.

1. Clinical Examination

A dermatologist or primary‑care physician will note the size, number, distribution, and texture of the plaques. They will also look for other xanthoma types and signs of systemic disease.

2. Blood Tests

• Lipid panel – total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Glucose testing – fasting glucose, HbA1c to assess diabetes.
• Liver function tests – ALT, AST, alkaline phosphatase, bilirubin.
• Kidney function – serum creatinine, urine protein quantification.
• Thyroid panel – TSH and free T4.
• Genetic testing (e.g., LDLR, APOE) when familial hyperlipidemia is strongly suspected.

3. Imaging & Other Tests

• Ultrasound or CT of the abdomen when liver disease is suspected.
• Echocardiography or coronary calcium scoring if cardiovascular risk is high.
• Skin biopsy (rare) – confirms lipid‑laden macrophages (foam cells) if the diagnosis is uncertain.

4. Differential Diagnosis

Conditions that can mimic xanthomas include granuloma annulare, psoriasis, and lichen planus. Laboratory data and histology help differentiate them.

Treatment Options

Therapy focuses on two goals: treating the skin lesions and correcting the underlying metabolic abnormality.

1. Addressing the Underlying Cause

• Lipid‑lowering medications – Statins (e.g., atorvastatin, rosuvastatin) are first‑line for high LDL; fibrates (fenofibrate) or omega‑3 fatty acids help high triglycerides.
• PCSK9 inhibitors – alirocumab or evolocumab for severe familial hypercholesterolemia.
• Ezetimibe – blocks intestinal cholesterol absorption, useful adjunctively.
• Management of diabetes – lifestyle changes, metformin, GLP‑1 agonists, or insulin as indicated.
• Treatment of liver or kidney disease – specific disease‑modifying agents (e.g., ursodeoxycholic acid for primary biliary cholangitis).
• Thyroid hormone replacement – levothyroxine for hypothyroidism.
• Discontinue or replace offending medications when possible.

2. Direct Management of Xanthomas

• Topical therapies – Limited efficacy, but retinoids (tretinoin) can modestly improve plaque texture.
• Laser therapy – CO₂ or Nd:YAG lasers may reduce lesion thickness, especially for cosmetic concerns.
• Surgical excision – Reserved for large, symptomatic plaques that do not respond to medical therapy.
• Cryotherapy – Occasionally used for small eruptive lesions.

3. Lifestyle Modifications

• Adopt a heart‑healthy diet: high in soluble fiber, low in saturated fats, trans‑fat, and refined carbohydrates.
• Engage in regular aerobic exercise (150 min/week of moderate intensity).
• Maintain a healthy weight – weight loss improves triglyceride levels.
• Avoid tobacco and limit alcohol, both of which raise triglycerides.

Prevention Tips

While not all cases are preventable (e.g., genetic hypercholesterolemia), the following measures can reduce risk or delay onset:

• Screen lipid levels at least once every 5 years, earlier if you have a family history of early heart disease.
• Control blood glucose aggressively if you have diabetes or pre‑diabetes.
• Stay up‑to‑date with vaccinations for hepatitis and other liver‑affecting infections.
• Report any new skin changes to your clinician promptly.
• If you take medications known to raise lipids, ask your provider about periodic lipid monitoring.

Emergency Warning Signs

Key Take‑aways

Yellow plaques on the elbows are a visual clue that your body may be storing excess lipids under the skin. While they can be harmless in isolation, they are most often a marker for potentially serious metabolic disorders such as familial hypercholesterolemia, diabetes, or liver disease. Early detection through a simple skin exam, paired with targeted blood tests, can uncover hidden health risks and allow timely treatment. Lifestyle changes, lipid‑lowering medications, and, when needed, procedural removal of the plaques can dramatically improve both appearance and overall cardiovascular prognosis.

---

References:

• Mayo Clinic. “Xanthomas.” Accessed April 2024. https://www.mayoclinic.org
• National Heart, Lung, & Blood Institute. “High Blood Cholesterol.” 2024. https://www.nhlbi.nih.gov
• Cleveland Clinic. “Familial Hypercholesterolemia.” 2023. https://my.clevelandclinic.org
• American Diabetes Association. “Standards of Care in Diabetes—2024.” https://diabetes.org
• World Health Organization. “Noncommunicable diseases: Cardiovascular diseases.” 2023. https://www.who.int
• U.S. National Library of Medicine. “Xanthoma.” MedlinePlus, 2024. https://medlineplus.gov

```